Survey exposes a crisis of avoidance in family caregiving
Older adults want to age at home: Just 1 in 5 have told loved ones what they actually want.
Pharmacy
Lilly strengthens neuroscience portfolio with Centessa acquisition
Eli Lilly completed acquiring Centessa Pharmaceuticals, adding orexin receptor 2 agonists for narcolepsy and sleep disorders as it expands its neuroscience pipeline.
RedSail rolls out RxMarket to help independent pharmacies combat margin pressure
RxMarket is free to join and use for pharmacies, with no contracts or purchasing commitments required.
SpecialtyRx reaches 350,000-patient milestone
The privately held company grew from three pharmacies in 2021 to 15 in less than five years.
WellSync’s BoomRx tops $70 million run rate
The prescription-management platform now serves over 4,500 clinics, processes 40,000+ orders monthly, and surpasses a $70 million annual rate within a year of launch.
Independent Pharmacy Cooperative and Nimble partner to help local pharmacies modernize and innovate
IPC members can now deliver seamless prescription access, mobile refills, and more through Nimble.
iA appoints CFO and EVP of Research & Development to advance next phase of growth
These appointments reflect iA’s ongoing investment in strengthening its leadership team and aligning capabilities across finance, technology, and product development.
Survey: Patients still face medication access barriers despite prior authorization reforms
National patient survey finds cost confusion, prior authorization delays can derail care, but technology can unlock price transparency, improv access.
PCMA files lawsuit to stop harmful Tennessee forced pharmacy closure legislation
"By forcing the closure of more than 160 PBM-affiliated retail, specialty, and mail-order pharmacies across the state, lawmakers are creating harmful new barriers for patients."
Long-term benefit of PBMs’ moves is uncertain
The test will be whether the shifts bring savings and less complexity for patients and pharmacies.
PRI report warns of risks tied to unauthorized GLP-1 knockoffs
A new Pacific Research Institute report warns that unauthorized compounded GLP-1 drugs may pose patient safety risks and hinder future pharmaceutical innovation.
Gilead mobilizes rapid donation of remdesivir to support Ebola response
Building on decade-long commitment to outbreak relief.
On the menu at Grocers: Simple, sustainable changes to boost health
Benefits from high-fiber foods include lower cholesterol, more balanced blood sugar levels and improved energy levels.
Amneal announces full study population interim Phase 4 ELEVATE-PD results, reinforcing previously reported benefits of CREXONT in Parkinson's Disease
Phase 4 ELEVATE-PD interim data from the entire study population (n=214) continue to show clinically meaningful, consistent benefits of CREXONT across all prior treatment groups.
